Equity Profile

ICLR

ICON Public Limited Company

Health CareLife Sciences Tools & Services$12.8B

May28Thu

Pre-Earnings Brief

UpcomingQ1-2026After Close5:00 PM EDT

Company Snapshot

ICON Public Limited Company (ICLR) operates in the health care sector, specifically in life sciences tools and services. The company plays a crucial role in supporting the development of new drugs and therapies, which is increasingly important as the demand for innovative health solutions grows globally.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well ICON is managing costs and generating income.

$2.43

Revenue

Revenue figures will provide insight into the company's overall sales performance and market demand for its services.

$2.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICLR Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.12%

Avg Stock Reaction

+1.30%

Last Quarter Recap

In the last quarter, ICON reported an EPS of $2.52, which was above expectations, leading to a positive stock reaction of +4.04%. However, revenue details were not disclosed, leaving some uncertainty.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect ICON to report solid earnings with an EPS of $2.43 and revenue of $2.0B. The market is keen to see if the company can continue its trend of beating earnings expectations.

Bull Case

If ICON exceeds the EPS estimate, it could reaffirm investor confidence and lead to a positive stock reaction, especially given its strong historical performance.

Bear Case

Conversely, if the company misses its earnings target, it may raise concerns about operational challenges or market demand, leading to a negative stock reaction.

Key Metrics to Watch

EPS

$2.43

Earnings per share is a key indicator of profitability and will show how well ICON is managing costs and generating income.

Revenue

$2.0B

Revenue figures will provide insight into the company's overall sales performance and market demand for its services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed $2.43, and by how much?

A significant beat could indicate strong operational performance and boost investor confidence.

What insights can management provide regarding revenue growth and market demand?

Understanding revenue performance will help gauge the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for ICON to exceed EPS expectations due to its strong historical performance and market position.

Supporting Evidence

ICON has consistently beaten EPS estimates in 86% of the last eight quarters.

The options market is pricing a move of 2.09%, which is higher than the historical average of 1.66%, indicating bullish sentiment.

Recent trends in the life sciences sector suggest increasing demand for the services ICON provides.

Key Risk

If the EPS comes in below $2.29, it could undermine the positive sentiment and lead to a reassessment of the company's growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will determine if ICON can maintain its positive earnings trajectory.

Bull Confirmed If

An EPS of $2.55 or higher would confirm strong operational performance and growth potential.

Bear Confirmed If

An EPS below $2.29 would raise concerns about the company's ability to meet market expectations.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.7%

Pricing rich

The options market is pricing in a potential move of about 2.09%, suggesting that traders expect some volatility around the earnings report.

Options are pricing ±2.1% while ICLR has averaged ±1.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

74.0%

Calls (174K)P/C Ratio: 0.19Puts (149K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICON beats expectations, history suggests a stock increase of around +1.22%, confirming the company's strong growth narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of around -0.96%, raising concerns about the company's operational challenges.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·2 sells

Members

House only

Est. Notional

$101,002.00–$265,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Management's outlook on market demand for life sciences services.
3Details on cost management strategies and their impact on margins.
4Insights into any challenges faced in the current operating environment.
5Future guidance on revenue expectations for the upcoming quarters.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

JOYY Inc.

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well ICON is managing costs and generating income.

$2.43

Revenue

Revenue figures will provide insight into the company's overall sales performance and market demand for its services.

$2.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICLR Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.12%

Avg Stock Reaction

+1.30%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect ICON to report solid earnings with an EPS of $2.43 and revenue of $2.0B. The market is keen to see if the company can continue its trend of beating earnings expectations.

Bull Case

If ICON exceeds the EPS estimate, it could reaffirm investor confidence and lead to a positive stock reaction, especially given its strong historical performance.

Bear Case

Conversely, if the company misses its earnings target, it may raise concerns about operational challenges or market demand, leading to a negative stock reaction.

Key Metrics to Watch

EPS

$2.43

Earnings per share is a key indicator of profitability and will show how well ICON is managing costs and generating income.

Revenue

$2.0B

Revenue figures will provide insight into the company's overall sales performance and market demand for its services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed $2.43, and by how much?

A significant beat could indicate strong operational performance and boost investor confidence.

What insights can management provide regarding revenue growth and market demand?

Understanding revenue performance will help gauge the company's market position and future prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for ICON to exceed EPS expectations due to its strong historical performance and market position.

Supporting Evidence

ICON has consistently beaten EPS estimates in 86% of the last eight quarters.

The options market is pricing a move of 2.09%, which is higher than the historical average of 1.66%, indicating bullish sentiment.

Recent trends in the life sciences sector suggest increasing demand for the services ICON provides.

Key Risk

If the EPS comes in below $2.29, it could undermine the positive sentiment and lead to a reassessment of the company's growth prospects.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will determine if ICON can maintain its positive earnings trajectory.

Bull Confirmed If

An EPS of $2.55 or higher would confirm strong operational performance and growth potential.

Bear Confirmed If

An EPS below $2.29 would raise concerns about the company's ability to meet market expectations.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.7%

Pricing rich

The options market is pricing in a potential move of about 2.09%, suggesting that traders expect some volatility around the earnings report.

Options are pricing ±2.1% while ICLR has averaged ±1.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

74.0%

Calls (174K)P/C Ratio: 0.19Puts (149K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICON beats expectations, history suggests a stock increase of around +1.22%, confirming the company's strong growth narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of around -0.96%, raising concerns about the company's operational challenges.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·2 sells

Members

House only

Est. Notional

$101,002.00–$265,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Management's outlook on market demand for life sciences services.
3Details on cost management strategies and their impact on margins.
4Insights into any challenges faced in the current operating environment.
5Future guidance on revenue expectations for the upcoming quarters.